ArticleScientific reports2025
Development of Balangu seed mucilage nanoparticles fabricated through ultrasonication-antisolvent method for encapsulation of gallic acid.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gallic acid (GA) is a naturally occurring polyphenol offering a vast diversity of biological attributes. The objective of this study was to design, characterize, and assess GA-loaded Balangu seed mucilage (BSM) nanoparticles (NPs) via a newly developed ultrasonication-antisolvent method of NP preparation. GA-loaded BSM NPs displayed a round-shaped and homogenous morphology and possessed particle sizes of 20-320 nm with a GA loading efficiency of ~ 52.8% and zeta potential of - 29.5 mV. The thermal behavior of NPs and the bioactive-carrier interaction were studied by thermogravimetric analysis (TGA) and Fourier transform infrared (FTIR) spectroscopy, respectively. The FTIR results revealed that GA successfully entrapped into the mucilage NPs. However, there was a diverse thermal stability of the developed nano-system prior and following the GA encapsulation. Overall, the simultaneous application of ultrasonication and antisolvent approaches was found to be an effectual strategy to produce nanoscale structures and encapsulate biologically active ingredients like GA that may find uses in food/pharmaceutical industries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.